S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.
about
S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domainsSensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase: IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTHAmphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE bindingThe amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivThe danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammationS100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regenerationThe S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets.Human muscle satellite cells show age-related differential expression of S100B protein and RAGERole of S100A1 in hypoxia-induced inflammatory response in cardiomyocytes via TLR4/ROS/NF-κB pathway.S100 proteins in cartilage: role in arthritis.Pathogenesis of malaria and clinically similar conditions.RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.An image analysis method for the precise selection and quantitation of fluorescently labeled cellular constituents: application to the measurement of human muscle cells in culture.The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.Functions of S100 proteins.Inflammation-associated S100 proteins: new mechanisms that regulate function.Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-αS100B impairs glycolysis via enhanced poly(ADP-ribosyl)ation of glyceraldehyde-3-phosphate dehydrogenase in rodent muscle cells.Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation.S100B protein in tissue development, repair and regeneration.S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation.Advanced glycation end products (AGEs) activate mast cells.Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy.Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia.GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury.
P2860
Q21135467-866C922E-72C8-455D-A92D-C4284347D513Q24310573-30C3E978-31E0-4053-A68A-9C230362FB96Q24338574-BBEB7765-E87E-4996-B992-58FE01A066D2Q24804328-A71C342A-C65B-480F-8771-EA6ECFD853A8Q28566413-35E440B2-4190-4334-91AC-68AA3E643E27Q28579193-41537B19-3128-4EA8-A7FE-02A75569194CQ28582320-C0820A21-F95F-4E4D-8DD2-5D12BAA27C83Q33851482-342E3BB3-5A49-43BD-98E5-2BB2D9DAD722Q34106243-20C37320-06D4-460C-AB93-942F7B8D1B26Q34140133-98643E47-8EAD-48C4-BCBB-32D029996B57Q34238722-20EBD89E-F9A2-493F-B859-67BFC7A8A8F1Q35040061-DAE3D98D-2DB1-444D-A93E-A3A98321A84CQ35562286-BFB4A297-3409-4D0F-B711-5294E6390B4DQ35603727-2D5DCC6A-305D-40E9-926E-D7B0FB45D3E9Q35803078-2D4FA298-55B7-4750-B96A-B522C4889029Q35838590-558B017B-C9CA-452E-9FA5-22D8ADC939AFQ35963173-785A1D1A-EE47-42AF-BE11-E0CA9124551DQ36085629-25543A00-5D67-42F7-AA98-6CA122971C17Q36857011-152A442A-8847-4C74-A2D4-62751CDD579EQ37001259-5C5143E1-F7BA-4ADB-B5F2-37FCD03C825FQ37705110-CF00C01E-CDFE-4285-A7E8-B419E30CF0F1Q38662525-2BB4EFF0-EEC7-4F21-8B05-FD74B6B5D801Q38717429-2078D92C-5858-4C3B-8F1B-500402B89650Q39176194-0AB1C403-BD8B-4E78-8CCB-65981C2F8322Q39752451-EDC87BC7-E570-49F0-8721-FB399C7CAF79Q40486252-FE7329B9-5CA7-43A6-8338-62FA642776EFQ41682122-BFF2CC37-C93B-4B4C-B780-E30D3435A1D8Q42277371-9A8C570A-8FEE-4F2C-A858-8D3FAC55520FQ46945614-B16777A2-343F-4F12-8403-B1A906B10D37Q54981970-676A3F25-60CB-43E2-AF5F-08F12702FC0F
P2860
S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@en
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@nl
type
label
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@en
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@nl
prefLabel
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@en
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@nl
P2093
P2860
P1476
S100B inhibits myogenic differ ...... in a RAGE-independent manner.
@en
P2093
Anna Lisa Agneletti
Cristina Marchetti
Francesca Riuzzi
Guglielmo Sorci
Rosario Donato
P2860
P304
P356
10.1128/MCB.23.14.4870-4881.2003
P407
P577
2003-07-01T00:00:00Z